Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:physicist
|
| gptkbp:aimsTo |
genetic disorders
genetic diseases crop yields innovation in genetics improve genetic research |
| gptkbp:basedOn |
gptkb:United_States
|
| gptkbp:collaborates_with |
biotechnology companies
|
| gptkbp:contributedTo |
scientific research
|
| gptkbp:dedicatedTo |
patient-centered solutions
advancing science and technology |
| gptkbp:develops |
genome editing tools
|
| gptkbp:engagements |
environmental sustainability initiatives
|
| gptkbp:established |
2015
|
| gptkbp:expansion |
international markets
|
| gptkbp:has_a |
collaborative research
|
| gptkbp:has_a_focus_on |
research and development
CRISPR technology precision medicine healthcare_solutions |
| gptkbp:has_a_mission_to |
advance genetic technologies
|
| gptkbp:has_partnerships_with |
academic institutions
|
| gptkbp:heldIn |
global partnerships
|
| https://www.w3.org/2000/01/rdf-schema#label |
Horizon Genome Editing
|
| gptkbp:is_a_member_of |
biotechnology associations
|
| gptkbp:is_a_resource_for |
educational purposes
|
| gptkbp:is_committed_to |
sustainable practices
ethical research practices diversity in science |
| gptkbp:is_involved_in |
clinical trials
community outreach programs public-private partnerships regenerative medicine agricultural biotechnology |
| gptkbp:is_known_for |
cutting-edge research
high-quality reagents |
| gptkbp:is_part_of |
the biotech ecosystem
|
| gptkbp:is_recognized_for |
industry awards
innovative solutions scientific contributions |
| gptkbp:leadership |
genome editing industry
|
| gptkbp:number_of_teams |
scientists and researchers
|
| gptkbp:offers |
gene editing services
|
| gptkbp:offersServices |
gene therapy
gene editing projects |
| gptkbp:participatesIn |
scientific conferences
|
| gptkbp:products |
life_sciences
|
| gptkbp:provides |
genetic mechanisms
startups in biotechnology genetic engineering solutions |
| gptkbp:provides_access_to |
genome editing reagents
|
| gptkbp:providesTrainingFor |
researchers
|
| gptkbp:range |
patented technologies
|
| gptkbp:receives_funding_from |
venture capital firms
|
| gptkbp:specializesIn |
precision gene editing
|
| gptkbp:supports |
therapeutic development
|
| gptkbp:utilizes |
advanced molecular techniques
|
| gptkbp:vision |
transform healthcare
|